期刊文献+
共找到253篇文章
< 1 2 13 >
每页显示 20 50 100
DTI and pathological changes in a rabbit model of radiation injury to the spinal cord after ^(125)I radioactive seed implantation 被引量:4
1
作者 Xia Cao Le Fang +2 位作者 Chuan-yu Cui Shi Gao Tian-wei Wang 《Neural Regeneration Research》 SCIE CAS CSCD 2018年第3期528-535,共8页
Excessive radiation exposure may lead to edema of the spinal cord and deterioration of the nervous system. Magnetic resonance imaging can be used to judge and assess the extent of edema and to evaluate pathological ch... Excessive radiation exposure may lead to edema of the spinal cord and deterioration of the nervous system. Magnetic resonance imaging can be used to judge and assess the extent of edema and to evaluate pathological changes and thus may be used for the evaluation of spinal cord injuries caused by radiation therapy. Radioactive ^125I seeds to irradiate 90% of the spinal cord tissue at doses of 40–100 Gy (D90) were implanted in rabbits at T10 to induce radiation injury, and we evaluated their safety for use in the spinal cord. Diffusion tensor imaging showed that with increased D90, the apparent diffusion coefficient and fractional anisotropy values were increased. Moreover, pathological damage of neurons and microvessels in the gray matter and white matter was aggravated. At 2 months after implantation, obvious pathological injury was visible in the spinal cords of each group. Magnetic resonance diffusion tensor imaging revealed the radiation injury to the spinal cord, and we quantified the degree of spinal cord injury through apparent diffusion coefficient and fractional anisotropy. 展开更多
关键词 nerve regeneration brachytherapy ^125I radioactive seeds magnetic resonance imaging radiation injury of the spinal cord diffusion tensor imaging apparent diffusion coefficient fractional anisotropy neural regeneration
下载PDF
Accelerated partial breast irradiation: Past, present, and future
2
作者 Anne W Tann Sandra S Hatch +2 位作者 Melissa M Joyner Lee R Wiederhold Todd A Swanson 《World Journal of Clinical Oncology》 CAS 2016年第5期370-379,共10页
Accelerated partial breast irradiation(APBI) focuses higher doses of radiation during a shorter interval to the lumpectomy cavity, in the setting of breast conserving therapy for early stage breast cancer. The utiliza... Accelerated partial breast irradiation(APBI) focuses higher doses of radiation during a shorter interval to the lumpectomy cavity, in the setting of breast conserving therapy for early stage breast cancer. The utilization of APBI has increased in the past decade because of the shorter treatment schedule and a growing body of outcome data showing positive cosmetic outcomes and high local control rates in selected patients undergoing breast conserving therapy. Technological advances in various APBI modalities, including intracavitary and interstitial brachytherapy, intraoperative radiation therapy, and external beam radiation therapy, have made APBI more accessible in the community. Results of early APBI trials served as the basis for the current consensus guidelines, and multiple prospective randomized clinical trials are currently ongoing. The pending long term results of these trials will help us identify optimal candidates that can benefit from ABPI. Here we provide an overview of the clinical and cosmetic outcomes of various APBI techniques and review the current guidelines for selecting suitable breast cancer patients. We also discuss the impact of APBI on the economics of cancer care and patient reported quality of life. 展开更多
关键词 BREAST cancer intracavitary brachytherapy ACCELERATED partial BREAST IRradiation INTERSTITIAL brachytherapy
下载PDF
An <i>In-Vivo</i>Study during Combined Intracavitary and Interstitial Brachytherapy of Gynaecological Malignancies Using microMOSFET
3
作者 Ramapandian Seenisamy Vivekanandan Nagarajan +4 位作者 Ashutosh Mukherji Parthasarathy Vedasoundaram K. S. Reddy Vivekanandam Singhavajala Vijayaprabhu Neelakandan 《International Journal of Medical Physics, Clinical Engineering and Radiation Oncology》 2017年第2期162-173,共12页
Aim: To analyze the inter-fraction, intra-fraction uncertainties and to verify the delivered total dose with planned dose in the combined intracavitary-interstitial brachytherapy of gynaecological cancer patients usin... Aim: To analyze the inter-fraction, intra-fraction uncertainties and to verify the delivered total dose with planned dose in the combined intracavitary-interstitial brachytherapy of gynaecological cancer patients using microMOSFET in-vivo dosimeter. Materials and Methods: Between May 2014 and March 2016, 22 patients who underwent brachytherapy treatments with an applicator combination of CT/MR compatible tandem, ring and Syed-Neblett template-guided rigid needles were included in this study. Specially designed microMOSFET, after calibration, was used to analyze the variations in dosimetry of combined intracavitary-interstitial application. Results: The standard deviation for Inter-fraction variation among 22 combined intracavitary interstitial applications ranged between 0.86% and 10.92%. When compared with the first fraction dose, the minimum and maximum dose variations were &minus;9.5% and 26.36%, respectively. However, the mean doses varied between &minus;5.95% and 14.49%. Intra-fraction variation, which is the difference of TPS calculated dose with first fraction microMOSFET-measured dose ranges from &minus;6.77% to 8.68%. The variations in the delivered total mean dose in 66 sessions with planned doses were &minus;3.09% to 10.83%. Conclusions: It is found that there was a gradual increase in microMOSFET measured doses as compared to the first fraction with that of subsequent fractions in 19 out of 22 applications. Tumor deformation and edema may be the influencing factors, but the applicator movements played a major role for the variations. We find that the microMOSFET is an easy and reliable system for independent verification of uncertainties during ICBT-ISBT treatments. 展开更多
关键词 microMOSFET Intra-Fraction VARIATIONS in brachytherapy Inter-Fraction VARIATIONS in brachytherapy COMBINED intracavitary and Interstitial brachytherapy In-Vivo Dosimetry in brachytherapy Applicator Displacement brachytherapy Uncertainties
下载PDF
Organ at Risk Doses during High Dose Rate Intracavitary Brachytherapy for Cervical Cancer: A Dosimetric Study
4
作者 N. V. Vinin Joneetha Jones +6 位作者 V. T. Ajas Geetha Muttath C. A. Suja E. K. Nabeel Yahiya P. N. Shoaib Nawaz Arun P. Narendran P. Shimjith 《International Journal of Medical Physics, Clinical Engineering and Radiation Oncology》 2018年第4期472-478,共7页
Background: Treatment of Cervical cancer includes a combination of external beam radiotherapy (EBRT) with intracavitary brachytherapy (ICBT). ICBT helps to boost radiation dose to primary disease. Organs like rectum, ... Background: Treatment of Cervical cancer includes a combination of external beam radiotherapy (EBRT) with intracavitary brachytherapy (ICBT). ICBT helps to boost radiation dose to primary disease. Organs like rectum, bladder, sigmoid and small bowel lie close to the cervix region and these organs receive dose from EBRT as well as ICBT and we want to know the dose to these organ at risk (OAR). Materials & Methods: Dosimetric details of 174 ICBT applications done in 58 patients were retrospectively analysed. All patients received EBRT dose of 50.4 Gy in 28 fractions. All patients had ICBT, three sessions with 7 Gy prescribed to point A. Dosimetric data including dose to right and left point A and dose to OARs were recorded from Oncentra Planning System. Results: Mean dose to point A on right side was 6.89 Gy and left side was 6.91 Gy. Mean D2cc dose to rectum, bladder, sigmoid and small bowel was 3.5 Gy, 5.25 Gy, 4.75 Gy and 4.2 Gy respectively. Mean EQD2 dose combining EBRT and ICBT in point A was 78.7 Gy on right side and 79 Gy on left side. Mean EQD2 doses to D2cc of rectum, bladder, sigmoid and small bowel was 62 Gy, 74.4 Gy, 70.5 Gy and 66.5 Gy respectively. Conclusion: From the results of this dosimetric study it is evident that OARs like rectum, sigmoid, bladder & bowel are receiving only acceptable doses of radiation using point A prescribed CT based ICBT planning. Hence with regards to OAR doses, CT based ICBT planning with dose prescribed to point A is a feasible option. 展开更多
关键词 intracavitary brachytherapy CARCINOMA CERVIX ORGAN at Risk High DOSE Rate brachytherapy
下载PDF
An Innovative Concept of High-Dose-Rate (HDR) Intracavitary Brachytherapy with an Intrauterine Inflatable Balloon for Endometrial Carcinoma
5
作者 Abhilasha Patel Shannon Cummins +1 位作者 Join Y. Luh Tony Eng 《Journal of Cancer Therapy》 2014年第9期878-883,共6页
Purpose: Curative radiation therapy is an established treatment option for non-surgical patients with early-stage endometrial carcinoma. Dosimetric analyses were performed using a single tandem, double tandem, Heyman ... Purpose: Curative radiation therapy is an established treatment option for non-surgical patients with early-stage endometrial carcinoma. Dosimetric analyses were performed using a single tandem, double tandem, Heyman capsules, and an inflatable intrauterine balloon to assess the dose homogeneity and conformality in the definitive treatment of inoperable endometrial cancer. Methods and Materials: Patients’ informed-consent was obtained. Dosimetric analyses were performed using four different after-loading applicators to assess the dose homogeneity and conformality of isodose to the three-dimensional (3-D) shape of the target volume (uterus) based on CT data in four patients (n = 4). The single tandem and double tandems were standard Fletcher-type (Nucletron Corporation, Columbia, MD). Heyman capsules were the disposable after-loading type (Radiation Products Design, Inc., Albertville, MN). The inflatable balloon with a central bi-lumen catheter was the Mammo Site Radiation Therapy System (Proxima Therapeutics, Alpharetta, GA) that is currently used for local breast brachytherapy. Treatment planning and dosimetric analyses for all four techniques were done with HDR PLATO Brachytherapy (v14.2.3) Software (Nucletron Corporation). Results: The average dose gradient within the target (uterine wall) is highest with the tandem methods, followed by Heyman capsules. The intrauterine balloon method showed the least dose gradient across the uterine wall. The corresponding average homogeneity indices were 3.81, 3.83, 2.97, 2.50 for single tandem, double tandem, Heyman capsules, and intrauterine balloon respectively. Conclusions: The intra-uterine inflatable balloon appears to have the best overall dosimetric advantages for the treatment of the uterine wall. Furthermore, the potential ease of use, shorter time of applicator placement, and better patient comfort warrant further investigation and subsequent clinical implementation. 展开更多
关键词 intracavitary BALLOON brachytherapy HIGH-DOSE-RATE ENDOMETRIAL Cancer
下载PDF
Radiation Oncology and Medical Devices(Part 2)
6
作者 Ning J.Yue Ting Chen Wei Zou 《中国医疗设备》 2014年第2期1-10,共10页
Radiation oncology is one of the three major treatment modalities to manage cancer patient cares,and is a discipline mainly driven by technology and medical devices.Modern radiation treatments have become fairly compl... Radiation oncology is one of the three major treatment modalities to manage cancer patient cares,and is a discipline mainly driven by technology and medical devices.Modern radiation treatments have become fairly complex and involve in utilizing a variety of medical devices to achieve the goal of providing conformal radiation dose coverage to the tumor target(s)while maximizing the sparing of normal organ structures.Recently,different forms of linear accelerators/radioactive source based machines have been invented and developed with the aim of providing improved treatments and more treatment options.Besides linear accelerators(Linac)that have been undergoing constant improvement and advancement and can deliver fairly complicated dose distribution patterns,imaging systems,computer information and calculation systems have been more and more integrated into radiotherapy processes.To bring radiotherapy to a potentially higher level,many institutions have either acquired or started to consider particle therapy,especially proton therapy.The complexity of modern radiotherapy demands in-depth understanding of radiation physics and machine engineering as well as computer information systems.This paper is intended to provide an introductory description of radiation oncology and related procedures,and to provide an overview of the current status of medical devices in radiotherapy in the United States of America.This paper covers the radiation delivery systems,imaging systems,treatment planning systems,record and verify systems,and QA systems. 展开更多
关键词 radiation oncology RADIOTHERAPY external beam radiotherapy brachytherapy intensity modulated radiotherapy SRS SBRT LINAC treatment planning system record and verify system 3DCRT Simulator
下载PDF
Radiation Oncology and Medical Devices( Part 1)
7
作者 岳宁 陈霆 邹薇 《中国医疗设备》 2014年第1期1-9,共9页
Modern radiation treatments have become fairly complex and involve in utilizing a variety of medical devices to achieve the goal of providing conformal radiation dose coverage to the tumor target(s)while maximizing th... Modern radiation treatments have become fairly complex and involve in utilizing a variety of medical devices to achieve the goal of providing conformal radiation dose coverage to the tumor target(s)while maximizing the sparing of normal organ structures.Recently,different forms of linear accelerators/radioactive source based machines have been invented and developed with the aim of providing improved treatments and more treatment options.Besides linear accelerators(Linac)that have been undergoing constant improvement and advancement and can deliver fairly complicated dose distribution patterns,imaging systems,computer information and calculation systems have been more and more integrated into radiotherapy processes.To bring radiotherapy to a potentially higher level,many institutions have either acquired or started to consider particle therapy,especially proton therapy.The complexity of modern radiotherapy demands in-depth understanding of radiation physics and machine engineering as well as computer information systems.This paper is intended to provide an introductory description of radiation oncology and related procedures,and to provide an overview of the current status of medical devices in radiotherapy in the United States of America.This paper covers the radiation delivery systems,imaging systems,treatment planning systems,record and verify systems,and QA systems. 展开更多
关键词 radiation oncology RADIOTHERAPY external beam radiotherapy brachytherapy intensity modulated radiotherapy SRS SBRT LINAC treatment planning system record and verify system 3DCRT simulator
下载PDF
Analysis of 80 Cases of Nasopharyngeal Carcinoma Treated by Intracavitary Brachytherapy Using A New-Type Applicator
8
作者 Zhongjie Chen Ruiying Li Ping Wang 《Chinese Journal of Clinical Oncology》 CSCD 2007年第1期52-55,共4页
OBJECTIVE To evaluate the results and complications associated with nasopharyngeal carcinoma (NPC) treated with combined external-beam radiotherapy (EBR) and intracavitary brachytherapy (IB) using a new-type applicato... OBJECTIVE To evaluate the results and complications associated with nasopharyngeal carcinoma (NPC) treated with combined external-beam radiotherapy (EBR) and intracavitary brachytherapy (IB) using a new-type applicator. METHODS Eighty patients with untreated NPC were divided into two groups based on therapy methods. An experimental group was treated with EBR plus IB and a control group was treated only with EBR. IB was given to the patients of the experimental group when the external radiotherapy dose amounted to more than 60~65 Gy. The total dose of IB was 6~20 Gy and the total dose of EBR of the control group was 70~75 Gy. RESULTS Follow-up was conducted for 97.5% of the patients with results as follows: the overall response rates (ORR) for the experimental and the control groups were 92.5% and 75.3% respectively (P<0.05); the 3 and 5-year survival rates for the experimental group were 87.5% and 74.2% and for the control group, 65.0% and 55.6% (P<0.05); for the experimental group, the 3 and 5-year disease-free survival rates were 72.5% and 64.5% and for the control group, 60.0% and 52.8% (P>0.05).Some complications following radiotherapy showed a signi fi cant difference. CONCLUSION External irradiation plus intracavitary brachytherapy using a new-type applicator may improve the ORR and survival rates, reduce radiation complications and increase the quality of life. 展开更多
关键词 鼻咽癌 放射疗法 腔内短程治疗 新型涂药器 应用
下载PDF
局部晚期直肠癌腔内近距离放疗器官保留研究进展
9
作者 程天 彭冉 +1 位作者 曲昂 王皓 《现代肿瘤医学》 CAS 2024年第5期937-941,共5页
腔内近距离放疗(intracavitary brachytherapy,ICBT)将放射源置于直肠腔内或肿瘤附近,可给予高剂量、高效率、低毒性、低成本的放射治疗。本文综述了两类ICBT在局部晚期直肠癌(locally advanced rectal cancer,LARC)器官保留治疗中的临... 腔内近距离放疗(intracavitary brachytherapy,ICBT)将放射源置于直肠腔内或肿瘤附近,可给予高剂量、高效率、低毒性、低成本的放射治疗。本文综述了两类ICBT在局部晚期直肠癌(locally advanced rectal cancer,LARC)器官保留治疗中的临床效果和安全性,并讨论了ICBT在实现器官保存和改善患者生活质量的潜在优势和挑战。ICBT联合或不联合外照射放疗是LARC器官保留治疗的有效手段,可带来临床获益,但仍需谨慎选择合适的患者。 展开更多
关键词 局部晚期直肠癌 腔内近距离放疗 器官保留 综述文献
下载PDF
宫颈癌根治术联合新辅助化疗与腔内近距离后装放疗治疗局部晚期宫颈癌的临床效果
10
作者 姚涓 邵佳 +1 位作者 徐海波 陈蕾 《中外医药研究》 2024年第6期36-38,共3页
目的:分析宫颈癌根治术联合新辅助化疗与腔内近距离后装放疗治疗局部晚期宫颈癌(LACC)的临床效果。方法:选取2014年1月—2018年6月南通大学附属肿瘤医院收治的Ⅰb2期、Ⅱa2期LACC患者86例作为研究对象,采用随机数字表法分为观察组(n=46... 目的:分析宫颈癌根治术联合新辅助化疗与腔内近距离后装放疗治疗局部晚期宫颈癌(LACC)的临床效果。方法:选取2014年1月—2018年6月南通大学附属肿瘤医院收治的Ⅰb2期、Ⅱa2期LACC患者86例作为研究对象,采用随机数字表法分为观察组(n=46)和对照组(n=40)。对照组行宫颈癌根治术,观察组在术前行新辅助化疗及腔内近距离后装放疗。比较两组手术情况、术后住院时间、不良反应发生情况及生存情况。结果:观察组手术时间、术后住院时间短于对照组,术中出血量少于对照组,差异有统计学意义(P<0.05);两组输尿管尿瘘、尿潴留、肾积水、肠梗阻、下肢静脉血栓、盆腔淋巴囊肿合并感染发生率比较,差异无统计学意义(P>0.05);两组3年无进展生存率、3年总生存率、中位生存时间比较,差异无统计学意义(P>0.05)。结论:宫颈癌根治术联合新辅助化疗与腔内近距离后装放疗治疗LACC的临床效果较好,可缩短手术治疗时间、减少术中出血量,加快术后恢复,且不会增加不良反应发生风险,不影响预后效果。 展开更多
关键词 宫颈癌 新辅助化疗 腔内近距离后装放疗 根治性手术 生存期
下载PDF
阴道填塞溻渍法治疗宫颈癌近距离放疗后阴道损伤的疗效观察
11
作者 齐子威 袁香坤 刘琼 《中医肿瘤学杂志》 2024年第3期37-42,共6页
目的研究中医特色填塞溻渍疗法治疗宫颈癌近距离放疗后阴道损伤的疗效。方法将60例近距离放疗后出现放射性阴道损伤的患者随机分为观察组、对照组,每组30例。观察组予以中药阴道溻渍填塞治疗,每日1次,每次3 h。对照组予以三乙醇胺乳膏... 目的研究中医特色填塞溻渍疗法治疗宫颈癌近距离放疗后阴道损伤的疗效。方法将60例近距离放疗后出现放射性阴道损伤的患者随机分为观察组、对照组,每组30例。观察组予以中药阴道溻渍填塞治疗,每日1次,每次3 h。对照组予以三乙醇胺乳膏阴道涂抹,每次3 mg,每日1次,均14天为1疗程。比较两组患者治疗前后临床疗效、阴道疼痛评分及阴道组织创面愈合时间。结果①两组治疗前后临床疗效比较:观察组与对照组总有效率分别为93.33%、70.00%,两组间差异有统计学意义(P<0.05)。②两组治疗后阴道疼痛评分比较,观察组疗效优于对照组,差异具有统计学意义(P<0.05)。③两组愈合时间比较:观察组创面完全疗愈合时间明显小于对照组,差异有统计学意义(P<0.05)。两组用药期间未见明显不良反应。结论中医特色填塞溻渍疗法在治疗宫颈癌近距离放疗后阴道损伤方面有效果,且在改善患者阴道疼痛评分、缩短创面愈合时间等方面,具有优势。 展开更多
关键词 放射性阴道炎 中医溻渍疗法 三乙醇胺 近距离放射治疗
下载PDF
Accelerated partial breast irradiation:Current evidence and future developments
12
作者 Dandan Song Honghong Zhang +3 位作者 Chengbo Ren Ning Zhan Liangxi Xie Wenjia Xie 《Cancer Innovation》 2024年第1期104-112,共9页
Whole breast irradiation after breast-conserving surgery for early breast cancer has become one of the standard treatment modes for breast cancer and yields the same effect as radical surgery.Accelerated partial breas... Whole breast irradiation after breast-conserving surgery for early breast cancer has become one of the standard treatment modes for breast cancer and yields the same effect as radical surgery.Accelerated partial breast irradiation(APBI)as a substitute for whole breast irradiation for patients with early breast cancer is a hot spot in clinical research.APBI is characterised by simple high-dose local irradiation of the tumour bed in a short time,thus improving convenience for patients and saving costs.The implementation methods of APBI mainly include brachytherapy,external beam radiation therapy,and intraoperative radiotherapy.This review provides an overview of the clinical effects and adverse reactions of the main technologies of APBI and discusses the prospects for the future development of APBI. 展开更多
关键词 accelerated partial breast irradiation brachytherapy breast cancer breast conserving surgery external beam radiation therapy intraoperative radiotherapy
原文传递
腔内联合组织间插植放疗与三维后装腔内放疗治疗局部晚期宫颈癌的疗效及剂量学参数比较
13
作者 邹育林 朱思瑾 谭嗣盟 《现代肿瘤医学》 CAS 2024年第1期115-120,共6页
目的:对比腔内联合组织间插植放疗(intracavitary/interstitial brachytherapy,IC-ISBT)与三维后装腔内放疗(intracavitary brachytherapy,ICBT)两种方式在宫颈癌近距离治疗中的疗效与剂量学差异。方法:回顾性分析2019年01月至2021年12... 目的:对比腔内联合组织间插植放疗(intracavitary/interstitial brachytherapy,IC-ISBT)与三维后装腔内放疗(intracavitary brachytherapy,ICBT)两种方式在宫颈癌近距离治疗中的疗效与剂量学差异。方法:回顾性分析2019年01月至2021年12月于我院接受根治性放疗的61例宫颈癌患者的资料,按照治疗方法不同分为IC-ISBT组和ICBT组,对比两组近期疗效、不良反应发生率以及剂量学差异。结果:IC-ISBT组的HR-CTV D_(90%)高于ICBT组,且差异有统计学意义(P=0.026);IC-ISBT组的直肠D_(2cm^(3))、D_(1cm^(3))和膀胱D_(2cm^(3))、D_(1cm^(3))显著低于ICBT组,差异有统计学意义(P<0.05);IC-ISBT组完全缓解率明显高于ICBT组,差异有统计学意义(P<0.05);IC-ISBT组放射性肠炎发生率明显低于ICBT组,差异有统计学意义(P<0.05)。结论:IC-ISBT治疗能显著提高靶区剂量的同时降低直肠、膀胱的受量,提高肿瘤客观缓解率,降低不良反应发生率。 展开更多
关键词 局部晚期宫颈癌 腔内联合组织间插植放疗 后装腔内放疗 剂量学 近期疗效
下载PDF
新辅助化疗联合局部热疗在局部晚期宫颈癌治疗中的疗效
14
作者 陈秋秋 黄辉 +4 位作者 孟娟 黄爽 陆玉松 潘旻 陈苑 《吉林医学》 CAS 2024年第7期1537-1541,共5页
目的:探讨新辅助化疗联合局部热疗在局部晚期宫颈癌治疗中的临床疗效、放疗总时间、加速器机器跳数及不良反应。方法:选取2019年9月~2022年9月桂林市人民医院40例局部晚期宫颈癌接受新辅助化疗联合局部热疗的患者作为观察组,对本组宫颈... 目的:探讨新辅助化疗联合局部热疗在局部晚期宫颈癌治疗中的临床疗效、放疗总时间、加速器机器跳数及不良反应。方法:选取2019年9月~2022年9月桂林市人民医院40例局部晚期宫颈癌接受新辅助化疗联合局部热疗的患者作为观察组,对本组宫颈癌患者给予2个疗程TPF方案新辅助化疗,每周期给予盆腔局部深部热疗2次;同时选取单独同期放化疗40例作为对照组;分析观察组新辅助化疗联合局部热疗的疗效、两组放射治疗总时间、加速器机器跳数及两组患者的不良反应发生情况。结果:观察组新辅助化疗联合局部热疗的客观缓解率(ORR)为87.5%(35/40),其中完全缓解(CR)为30%(12/40),部分缓解(PR)为57.5%(23/40),疾病稳定(SD)为12.5%(5/40);观察组新辅助化疗联合热疗前后肿瘤最大径分别为(5.31±1.72)cm、(2.12±1.35)cm,差异有统计学意义(t=9.401,P<0.01);观察组和对照组放射治疗时间分别为(42.15±2.75)d、(53.41±6.18)d,两组比较,差异有统计学意义(t=12.398,P<0.01);观察组和对照组外照射时单次外照射加速器机器跳数分别为(1347±129.14)MU、(1556±128.61)MU两组比较,差异有统计学意义(t=3.782,P<0.01)。结论:局部晚期宫颈癌新辅助化疗联合局部热疗患者临床治疗效果显著,新辅助化疗联合热疗后腔内后装放疗能与调强外照射放疗同时进行,缩短放疗时间,单次外照射加速器机器跳数明显减少,缩短单次治疗时间,减少加速器磨损。 展开更多
关键词 热疗 局部晚期宫颈癌 新辅助化疗 腔内后装放疗 调强外照射治疗
下载PDF
IMRT、3D-CRT联合腔内近距离放疗治疗宫颈癌的效果及预后比较
15
作者 曾庆范 王颖拓 华松 《实用癌症杂志》 2024年第5期837-840,共4页
目的比较调强放疗(IMRT)、三维适形放疗(3D-CRT)联合腔内近距离放疗治疗宫颈癌(CC)的效果及预后。方法将86例ⅡB~ⅢB期CC患者作为本次研究对象,应用随机信封法将患者分为2组,IMRT组(n=43,采用IMRT)与3D-CRT组(n=43例,采用3D-CRT),2组均... 目的比较调强放疗(IMRT)、三维适形放疗(3D-CRT)联合腔内近距离放疗治疗宫颈癌(CC)的效果及预后。方法将86例ⅡB~ⅢB期CC患者作为本次研究对象,应用随机信封法将患者分为2组,IMRT组(n=43,采用IMRT)与3D-CRT组(n=43例,采用3D-CRT),2组均联合腔内近距离放疗治疗,比较2组近期临床治疗效果、肿瘤标志物水平、放射性不良反应以及生活质量。结果IMRT组近期疗效为83.72%,高于3D-CRT组的74.42%,但差异无统计学意义(P>0.05)。治疗后IMRT组癌类抗原125(CA-125)与癌胚抗原(CEA)水平均低于3D-CRT组(P<0.05)。IMRT组放射性并发症总发生率低于3D-CRT组(P<0.05)。治疗后IMRT组生活质量核心调查评分表(QLQC-30)各维度评分均高于3D-CRT组(P<0.05)。结论IMRT、3D-CRT联合腔内近距离放疗治疗CC短期疗效相当,但IMRT抗CC作用更强,且不良反应少,更有利于提高患者生存质量。 展开更多
关键词 调强放疗 三维适形放疗 腔内近距离放疗 宫颈癌 肿瘤标志物 安全性
下载PDF
Rectal ulcer:Due to ketoprofen, argon plasma coagulation and prostatic brachytherapy 被引量:1
16
作者 Thibaud Koessler Vincent Servois +2 位作者 Pascale Mariani Emilie Aubert Wulfran Cacheux 《World Journal of Gastroenterology》 SCIE CAS 2014年第45期17244-17246,共3页
Prostatic brachytherapy with permanent seed implants is a recent and safe radiation therapy technique associated with radiation-induced digestive disease.Argon plasma coagulation procedure is a validated modality in t... Prostatic brachytherapy with permanent seed implants is a recent and safe radiation therapy technique associated with radiation-induced digestive disease.Argon plasma coagulation procedure is a validated modality in the management of haemorrhagic radiation proctitis,which is known to occasionally induce chronic rectal ulcers.We report here an original case report of an acute painful rectal ulcer as a consequence of the combination of shortterm therapy with non-steroidal anti-inflammatory drugs therapy,prostatic brachytherapy with malposition of seed implants and argon plasma coagulation procedure in a patient with haemorrhagic radiation proctitis.The description of this clinical observation is essential to recommend the discontinuation of non-steroidal anti-inflammatory drugs therapy and the control of the position of seed implants in case of prostatic brachytherapy before argon plasma coagulation for radiation-induced proctitis. 展开更多
关键词 radiation PROCTITIS PROSTATIC brachytherapy ARGON
下载PDF
Brachytherapy in cancer cervix: Time to move ahead from point A?
17
作者 Anurita Srivastava Niloy Ranjan Datta 《World Journal of Clinical Oncology》 CAS 2014年第4期764-774,共11页
Brachytherapy forms an integral part of the radiation therapy in cancer cervix. The dose prescription for intracavitary brachytherapy(ICBT) in cancer cervix is based on Tod and Meredith's point A and has been in p... Brachytherapy forms an integral part of the radiation therapy in cancer cervix. The dose prescription for intracavitary brachytherapy(ICBT) in cancer cervix is based on Tod and Meredith's point A and has been in practice since 1938. This was proposed at a time when accessibility to imaging technology and dose computation facilities was limited. The concept has been in practice worldwide for more than half a century and has been the fulcrum of all ICBT treatments, strategies and outcome measures. The method is simple and can be adapted by all centres practicing ICBT in cancer cervix. However, with the widespread availability of imaging techniques, clinical use of different dose-rates, availability of a host of applicators fabricated with image compatible materials, radiobiological implications of dose equivalence and its impact on tumour and organs at risk; more and more weight is being laid down on individualised image based brachytherapy. Thus, computed tomography, magnetic-resonance imaging and even positron emission computerized tomographyalong with brachytherapy treatment planning system are being increasingly adopted with promising outcomes. The present article reviews the evolution of dose prescription concepts in ICBT in cancer cervix and brings forward the need for image based brachytherapy to evaluate clinical outcomes. As is evident, a gradual transition from "point" based brachytherapy to "profile" based image guided brachytherapy is gaining widespread acceptance for dose prescription, reporting and outcome evaluation in the clinical practice of ICBT in cancer cervix. 展开更多
关键词 CANCER CERVIX intracavitary brachytherapy POINT A Image GUIDED brachytherapy Computed tomography-guided brachytherapy Magnetic resonance imaging-guided brachytherapy Ultrasound GUIDED brachytherapy
下载PDF
Comparison of Depth Dose Distributions Using Cerenkov Fiber-Optic Dosimeter and Monte Carlo Simulation for HDR Brachytherapy
18
作者 Sang Hun Shin Young Beom Song +4 位作者 Mingeon Kim Hye Jin Kim Wook Jae Yoo Kyoung Won Jang Bongsoo Lee 《Journal of Applied Mathematics and Physics》 2016年第8期1499-1502,共5页
In this study, we fabricated a Cerenkov fiber-optic dosimeter (CFOD) without any scintillator to measure Cerenkov radiation signals owing to gamma-rays. The relative depth dose (RDD) distributions of Ir-192 HDR brachy... In this study, we fabricated a Cerenkov fiber-optic dosimeter (CFOD) without any scintillator to measure Cerenkov radiation signals owing to gamma-rays. The relative depth dose (RDD) distributions of Ir-192 HDR brachytherapy source were obtained by using the CFOD based on a subtraction method and the RDD curve was compared with the simulation result of Monte Carlo N-particle extended transport code (MCNPX). Finally, we demonstrated that the CFOD can be used to measure real-time dose information for HDR brachytherapy. 展开更多
关键词 Cerenkov Fiber-Optic Dosimeter Cerenkov radiation GAMMA-RAY Relative Depth Dose HDR brachytherapy
下载PDF
两种补量技术在局部晚期宫颈癌近距离放射治疗中的剂量学比较
19
作者 谭华艳 叶萌 +5 位作者 容雁 邓烨 汪伦 梁刘可 高琨 付庆国 《医疗装备》 2023年第21期4-7,12,共5页
目的探讨三维腔内后装同步体外施源器引导调强放疗技术(ICBT+IMRT)与三维腔内联合组织间插植技术(IC/IS-BT)在局部晚期宫颈癌患者治疗中的剂量学差异。方法回顾性分析2015年3月至2018年8月医院收治的105例接受三维腔内后装放疗的局部晚... 目的探讨三维腔内后装同步体外施源器引导调强放疗技术(ICBT+IMRT)与三维腔内联合组织间插植技术(IC/IS-BT)在局部晚期宫颈癌患者治疗中的剂量学差异。方法回顾性分析2015年3月至2018年8月医院收治的105例接受三维腔内后装放疗的局部晚期宫颈癌患者的临床资料,根据不同腔内后装补量方式分为ICBT+IMRT组52例和IC/IS-BT组53例,比较两组肿瘤靶区(HR-CTV)和危及器官(OARs)的剂量学差异。结果ICBT+IMRT组和IC/IS-BT组的靶区体积比较,差异无统计学意义(P>0.05);ICBT+IMRT组的HR-CTV靶区覆盖度D100优于IC/IS-BT组,差异有统计学意义(P<0.05);两组的HR-CTV靶区覆盖度D90比较,差异无统计学意义(P>0.05)。ICBT+IMRT组的膀胱D1cc剂量略低于IC/IS-BT组,差异有统计学意义(P<0.05),但两组膀胱D2cc剂量比较,差异无统计学意义(P>0.05);ICBT+IMRT的直肠受量(D1cc、D2cc)均高于IC/IS-BT组,差异有统计学意义(P<0.05)。结论ICBT+IMRT组与IC/IS-BT组的肿瘤靶区剂量均能满足处方剂量要求,且靶区覆盖较好。虽然ICBT+IMRT组直肠受量稍高于IC/IS-BT组,但ICBT+IMRT补量技术具有操作简便、避免因插植针拔出后出血及感染的风险等优势,因此可作为IC/IS-BT技术组的补充或替代手段。 展开更多
关键词 局部晚期宫颈癌 后装 内外融合 腔内联合组织间插植 剂量学
下载PDF
高剂量率^(192)Irγ射线参考辐射场的搭建
20
作者 支世杰 王继 +2 位作者 王培玮 吴金杰 任世伟 《计量学报》 CSCD 北大核心 2023年第12期1882-1888,共7页
为完成高剂量率^(192)Ir放射源参考空气比释动能率的绝对测量工作,设计了专用的辐照器及定位装置,利用医用高剂量率近距离治疗机搭建了准直的参考辐射场。参考ISO 4037等相关标准,对参考辐射场的散射、辐射野、半值层、有效能量等相关... 为完成高剂量率^(192)Ir放射源参考空气比释动能率的绝对测量工作,设计了专用的辐照器及定位装置,利用医用高剂量率近距离治疗机搭建了准直的参考辐射场。参考ISO 4037等相关标准,对参考辐射场的散射、辐射野、半值层、有效能量等相关参数进行了测量和研究。结果显示,在辐射场多个位置,环境散射份额小于主射束的0.003%;在距离放射源1.4 m的位置,辐射野直径为98 mm,尺寸大于基准石墨空腔电离室;半值层测量结果为8.224 mm(Cu),有效能量为402.8 keV,利用HPGe探测器测量的^(192)Ir能谱与模拟谱契合度良好。各项参数均满足了^(192)Ir近距离治疗源参考空气比释动能率的量值复现要求,为其绝对测量与国际比对工作打下基础。 展开更多
关键词 电离辐射 参考空气比释动能率 近距离治疗 ^(192)Ir放射源
下载PDF
上一页 1 2 13 下一页 到第
使用帮助 返回顶部